COMMENT: Data today; a new tomorrow?
This article was originally published in Scrip
Executive Summary
As the European Medicines Agency warms up for its workshop on clinical trial data and transparency on 22 November, burgeoning pressure from public campaigners is driving the industry to speed up its efforts to come up with a response to calls for full data transparency that is rational, reasonable and comprehensive. Procrastination and resistance are choices (and the industry’s habitual option) but do they really serve?.